DB
EW icon

Dmitry Balyasny’s Edwards Lifesciences EW Stock Holding History

Dmitry Balyasny’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,600
Closed -$1.67M – 3066
2025
Q4 		$1.67M Sell
19,600
-31,500
-62% -$2.59M ﹤0.01% 1956
2025
Q3 		$3.97M Buy
51,100
+35,600
+230% +$2.78M 0.01% 1479
2025
Q2 		$1.21M Buy
15,500
+8,100
+109% +$604K ﹤0.01% 1971
2025
Q1 		$536K Sell
7,400
-263,600
-97% -$18.9M ﹤0.01% 2249
2024
Q4 		$20.1M Sell
271,000
-391,400
-59% -$27.4M 0.03% 669
2024
Q3 		$43.7M Buy
+662,400
New +$48.1M 0.07% 356
2024
Q2 		– Sell
-10,000
Closed -$956K – 2715
2024
Q1 		$956K Buy
+10,000
New +$840K ﹤0.01% 1812
2023
Q4 		– Sell
-422,500
Closed -$29.3M – 2597
2023
Q3 		$29.3M Buy
+422,500
New +$34M 0.06% 437
2022
Q3 		– Sell
-182,000
Closed -$17.3M – 2950
2022
Q2 		$17.3M Buy
+182,000
New +$18.8M 0.06% 467
2021
Q3 		– Sell
-7,300
Closed -$756K – 2079
2021
Q2 		$756K Buy
+7,300
New +$688K ﹤0.01% 1415
2019
Q4 		– Sell
-90,000
Closed -$6.6M – 1251
2019
Q3 		$6.6M Buy
+90,000
New +$6.32M 0.05% 498
2018
Q4 		– Sell
-342,000
Closed -$17M – 1491
2018
Q3 		$17M Buy
+342,000
New +$16.7M 0.08% 344
2017
Q1 		– Sell
-147,600
Closed -$4.61M – 1638
2016
Q4 		$4.61M Buy
+147,600
New +$4.78M 0.02% 705
2016
Q3 		– Sell
-900,000
Closed -$29.9M – 1073
2016
Q2 		$29.9M Buy
900,000
+480,000
+114% +$16.4M 0.19% 142
2016
Q1 		$12.3M Buy
420,000
+60,000
+17% +$1.66M 0.07% 347
2015
Q4 		$9.48M Sell
360,000
-1,060,200
-75% -$27.5M 0.07% 376
2015
Q3 		$33.7M Buy
+1,420,200
New +$34.3M 0.25% 114

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Dmitry Balyasny's EW Position: Q2 2026 in Review

Dmitry Balyasny increased its Edwards Lifesciences (EW) stake by 4,463% in Q2 2026, buying an estimated $37.4M and bringing the position to 456,202 shares worth $41.3M. The position accounts for 0.05% of the portfolio, ranked #425.

Dmitry Balyasny first reported a position in EW in Q2 2013 and has held it in 34 quarters since. The position peaked at $154M in Q1 2025. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Dmitry Balyasny held 456,202 shares of Edwards Lifesciences worth $41.3M as of Q2 2026.
  • Dmitry Balyasny bought 446,204 Edwards Lifesciences shares in Q2 2026, an estimated $37.4M.
  • Edwards Lifesciences made up 0.05% of Dmitry Balyasny's portfolio in Q2 2026, its #425 holding.
  • Dmitry Balyasny first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 34 quarters since.
  • Dmitry Balyasny's Edwards Lifesciences position peaked at $154M in Q1 2025.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.